ENLV Enlivex Therapeutics Ltd.

Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

$4.64  -0.02 (-0.43%)
As of 11/28/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  11/02/2017
Outstanding shares:  18,381,052
Average volume:  24,410
Market cap:   $86,023,323
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%